211 Ultrasound predictive factors for efficacy and safety of the use of Collagenase Clostridium Histolyticum (CCH) in the treatment of Peyronie's disease (PD): Impact of patient's selection

2018 ◽  
Vol 15 (7) ◽  
pp. S205
Author(s):  
E. Fernández-Pascual ◽  
J.I. Martínez-Salamanca ◽  
E. Cerezo ◽  
J. Minaya ◽  
J. Carballido
Sign in / Sign up

Export Citation Format

Share Document